Full Length Research Paper
References
|
Andre F (2006). Hepatitis B epidemiology in Asia, the Middle East and Africa. Epidemiologic Reviews 18:20-22. |
|
|
Arbab AH, Parvez MK, Al-Dosari MS, Al-Rehaily AJ (2017). In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus. Experimental and Therapeutic Medicine 14(1):626-634. |
|
|
Arbab AH, Parvez MK, Al-Dosari MS, Al-Rehaily AJ, Al-Sohaibani M, Zaroug EE, AlSaid MS, Rafatullah S (2015). Hepatoprotective and Antiviral Efficacy of Acacia mellifera Leaves Fractions against Hepatitis B Virus. Biomedical Research International Volume 2015 Article ID 929131, 10p. |
|
|
Bonino F, Hoyer B, Nelson J, Engle R, Verme G, Gerin J (1981). Hepatitis B virus DNA in the sera of HBsAg carriers: A marker of active hepatitis B virus replication in the liver. Hepatology 1:386-391. |
|
|
Chen Y, Zhu J (2013). Anti-HBV effect of individual traditional Chinese herbal medicine in vitro and in vivo: An analytic review. Journal of Viral Hepatitis 20:445-452. |
|
|
Deng L, Tang H (2011). Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sites. Hepatology Research 41:1017-1024. |
|
|
Doong SL, Tsai CH, Schinazi RF, Liotta DC, Cheng YC (1991). Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy 3'-thiacytidine and related analogues. Proceedings of the National Academy of Sciences 88:8495-8499. |
|
|
Fransworth NR (1966). Biological and phytochemical screening of plants. Journal of Pharmmaceutical Sciences 55:225-276. |
|
|
Gupta N, Goyal M, Wu CH, Wu GY (2014). The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide Analogs. Journal of Clininical and Translational Hepatology 2:202-211. |
|
|
Hantz O, Zoulim F (2004). Duck hepatitis B virus primary hepatocyte culture model. Methods in Molecular Medicine 96:189-197. |
|
|
Huang Si-Xin, Mou Jun-Fei, Qin Luo, Mo Qing-Hu, Zhou Xian-Li, Huang Xiao (2019) anti-hepatitis b virus activity of esculetin from Microsorium fortunei in vitro and in vivo. Molecules 24(19):3475. |
|
|
Jia W, Zhu MQ, Qi X, Wang T, Wen X, Chen PD, Fan QQ, Zhang W-H, Zhang JM (2019). Serum hepatitis B virus RNA levels as a predictor of HBeAg seroconversion during treatment with peginterferon alfa-2a. Virology Journal 16:61. |
|
|
Lin CL, Kao JH (2016). New perspectives of biomarkers for the management of chronic hepatitis B. Clinical and Molecular Hepatology 22(4):423-431. |
|
|
Marini-Bettolo GB, Nicoletti M, Patamia M, Galeffi C, Messana I (1981). Plant screening by chemical and chromatographic procedure under field conditions. Journal of Chromatography 213(1):113-217. |
|
|
Mothana RA , Lindequist U, Gruenert R, Bednarski PJ (2009). Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the Island Soqotra. BMC Complementary and Alternative MedicinE 9:7. |
|
|
Mothana RA, Mentel R, Reiss C, Lindequist U (2006). Phytochemical screening and antiviral activity of some medicinal plants from the island Soqotra. Phytotherapy Research 20(4):298-302. |
|
|
Parvez MK, Al-Dosari MS, Arbab AH, Niyazi S (2019). The in vitro and in vivo anti-hepatotoxic, anti-hepatitis B virus and hepatic CYP450 modulating potential of Cyperus rotundus. Saudi Pharmaceutical Journal 27(4):558-564. |
|
|
Parvez MK, Al-Dosari MS, Arbab AH, Al-Rehaily AJ, Abdelwahid MAS (2020). Bioassay-guided isolation of anti-hepatitis B virus flavonoid myricetin-3-O-rhamnoside along with quercetin from Guiera senegalensis leaves. Saudi Pharmaceutical Journal 28(5):550-559. |
|
|
Parvez MK, Arbab AH, Al-Dosari MS, Al-Rehaily AJ (2016). Antiviral Natural Products Against Chronic Hepatitis B: Recent Developments. Current Pharmaceutical Design 22:286-93. |
|
|
Schüpbach J, Böni J, Flepp M, Tomasik Z, Joller H, Opravil M (2001). Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: An inexpensive alternative to tests for viral RNA. Journal of Medical Virology 65:225-32. |
|
|
Shepard CW, Simard EP, Lyn Finelli AEF, Bell BP (2006). Hepatitis B Virus Infection: Epidemiology and Vaccination. Epidemiologic Reviews 28:112-125. |
|
|
Thung SN, Gerber MA, Purcell RH, London WT, Mihalik KB, Popper H (1981). Animal model of human disease. Chimpanzee carriers of hepatitis B virus. Chimpanzee hepatitis B carriers. The American Journal of Pathology 105:328-332. |
|
|
Torres C, Leone FGPY, Pezzano SC, Mbayed VA, Campos RH (2011). New perspectives on the evolutionary history of hepatitis B virus genotype F. Molecular Phylogenetics Evolution 59:114-122. |
|
|
Torresi J (2008). Hepatitis B antiviral resistance and vaccine escape: Two sides of the same coin. Antiviral Therapy 13:337-340. |
|
|
van Meerloo J, Kaspers GJ, Cloos J (2011). Cell sensitivity assays: The MTT assay. Methods in Molcular Biology 731:237-245. |
|
|
Wagner H, Bladt S (1996). Plants Drug Analysis: A Thin Layer Chromatography Atlas. 2nd edition. Springer, Berlin pp. 306-364. |
|
|
Wei J, Lin L, Su X, Qin S, Xu Q, Tang Z, Deng Y, Zhou Y, He S (2014). Anti hepatitis B virus activity of Boehmeria nivea leaf extracts in human HepG2.2.15 cells. Biomedical Reports 2(1):147-151. |
|
|
Wu C-C, Chen Y-S, Cao L, Chen X-W, Lu M-J (2018). Hepatitis B virus infection: Defective surface antigen expression and pathogenesis. World Journal of Gastroenterology 24(31):3488-3499. |
|
|
Wu Y-H (2016). Naturally derived anti-hepatitis B virus agents and their mechanism of action. World Journal of Gastroenterology 22(1):188-204. |
|
|
Yahaya A, Yola A, Babashani M (2006) . Comparative study on use of CD4 T cell count and plasma P24 antigen concentration in antiretroviral therapy monitoring for HIV/AIDs patients in Kano, Nigeria. Retrovirology 3(1):67. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
